TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BIOPHARM

OncologyImmunologyInfectious Disease
Generics

BIOPHARM is a generic drug manufacturer focused on Oncology, Immunology, Infectious Disease.

1997
Since
1
Drugs
-
Trials
28
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ETODOLAC 2024-11-22
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
ETODOLAC 2024-11-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 52%
0 drugs Phase 3: 66 Phase 2: 96 Phase 1: 318
Immunology 19%
1 drugs Phase 3: 43 Phase 2: 39 Phase 1: 30
Infectious Disease 14%
0 drugs Phase 3: 16 Phase 2: 51 Phase 1: 44
Neurology 9%
0 drugs Phase 3: 20 Phase 2: 21 Phase 1: 12
Dermatology 6%
0 drugs Phase 3: 11 Phase 2: 20 Phase 1: 13

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology
AbbVie big-pharma
Immunology, Oncology, Neurology, Infectious Disease
GSK big-pharma
Infectious Disease, Oncology, Immunology, Neurology
Eli Lilly big-pharma
Oncology, Immunology, Neurology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Infectious Disease, Neurology